Serum Soluble ST2 and Diastolic Dysfunction in Hypertensive Patients

Table 4

Serum sST2 levels of patients according to the presence of diastolic dysfunction and cardiovascular risk.

		ST2 (ng/mL)
E/e’m	≤8	30.67 ± 22.18	0.03^a
	9–12	33.34 ± 27.56	0.002^b
	≥13	42.16 ± 39.51	.000^c
Diastolic dysfunction	Absent	27.06 ± 12.97	.048^d
	Grade 1/mild	30.67 ± 21.06	.016^e
	Grade 2/moderate	43.54 ± 17.49	.008^f
Diabetes	Absent	32.76 ± 20.61	.002^g
	Present	39.16 ± 40.98
Additional CV risk	Moderate	23.66 ± 15.73	.020^h
	High	31.58 ± 20.96	.04^i
	Very high	40.16 ± 28.03	.026^j

^aE/e’ versus E/e’; ^bE/e’ versus E/e’; ^cE/e’ versus E/e’; ^dabsent versus grade 1; ^egrade 1 versus grade 2; ^fabsent versus grade 2; ^gabsent versus present; ^hmoderate versus high; ⁱhigh versus very high; ^jmoderate versus very high; CV: cardiovascular.